By Lorna Patrick, Chief Operating Officer, Upperton In the world of outsourced drug development and manufacturing, risk ...
Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon ...
Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.
Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...
Preliminary clinical results of the MYTHIC study will be presented, revealing for the first time data of the combination of WEE1 and PKMYT1 inhibition (zedoresertib and lunresertib) for the treatment ...
Waiv, formerly Owkin Dx, a company advancing AI precision testing, today announced that two of its AI precision tests, RlapsRisk ® BC for breast cancer prognostic risk profiling ...
Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median time on treatment ...
Debiopharm to present pre-clinical and clinical research advances in DDR inhibition, dual payload ADCs & AI-driven biomarkers at AACR 2026: Lausanne, Switzerland Thursday, April 1 ...
Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease ...
Great Smoky Cannabis Co. is reshaping the Eastern Band of Cherokee Indians economy, drawing support from marijuana consumers ...
In 20 years, the institution has seen the city change from a low-stakes, overachieving cultural incubator to the US’s hub of neoliberal corporate capitalism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results